LGND - Ligand Pharmaceuticals Incorporated
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$339.43
DETAILS
HIGH:
$358.00
LOW:
$326.00
MEDIAN:
$340.00
CONSENSUS:
$339.43
UPSIDE:
12.46%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 3,610 | $1.1M | 0.0% | -562 | DECREASED |
| Cooperman | 2,800 | $885,052 | 0.0% | +600 | INCREASED |
| Wood | 800 | $252,872 | 0.0% | +800 | INCREASED |
| Dalio | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 833 | $302.51 | $252K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,976 | $303.54 | $600K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,535 | $304.52 | $467K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 404 | $306.18 | $124K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 17 | $307.74 | $5K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | SELL | 235 | $307.19 | $72K |
| 2026-10-02 | Reardon Andrew | officer: CLO & Secretary | M-Exempt | 340 | $52.27 | $18K |
| 2026-09-22 | Zimmermann Martine | director | F-InKind | 115 | $298.50 | $34K |
| 2026-09-10 | Zimmermann Martine | director | SELL | 1,200 | $285.00 | $342K |
| 2026-09-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 300 | $283.99 | $85K |
| 2026-09-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 1,800 | $285.17 | $513K |
| 2026-09-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 2,115 | $286.36 | $606K |
| 2026-09-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 385 | $287.53 | $111K |
| 2026-09-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 400 | $288.98 | $116K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 3,348 | $68.74 | $230K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 7,171 | $57.22 | $410K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 2,869 | $55.75 | $160K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | SELL | 31,641 | $292.06 | $9.2M |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 16,179 | $52.84 | $855K |
| 2026-08-12 | Espinoza Octavio | officer: Chief Financial Officer | M-Exempt | 2,074 | $70.04 | $145K |
| 2026-08-12 | Haas Jason | director | M-Exempt | 6,138 | $51.56 | $316K |
| 2026-08-12 | Haas Jason | director | SELL | 7,138 | $292.81 | $2.1M |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 105 | $284.14 | $30K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 33 | $284.55 | $9K |
| 2026-08-03 | Reardon Andrew | officer: CLO & Secretary | SELL | 157 | $285.74 | $45K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-06-09 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |